Amgen (AMGN) reported Q2 FY 2021 earnings of $4.38 per share (versus $4.25 per share in Q2 FY 2020), beating analysts’ consensus estimate of $4.01 per share.
The company’s quarterly revenues amounted to $6.526 bln (+5.2% y/y), beating analysts’ consensus estimate of $6.451 bln.
AMGN closed Tuesday’s trading session at $244.08 (+1.79%).